Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress

Antioxidants and Redox Signaling

Volumn 14, Issue 7, 2011, Pages 1191-1202

  Koga, Kiyokazu ^a   Kenessey, Agnes ^a   Powell, Saul R ^a   Sison, Cristina P ^a   Miller, Edmund J ^a   Ojamaa, Kaie ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; CYTOCHROME C; GLUTATHIONE; GLUTATHIONE DISULFIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; REACTIVE OXYGEN METABOLITE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART PROTECTION; IN VIVO STUDY; ISCHEMIA; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION; REPERFUSION INJURY; WILD TYPE;

ACONITATE HYDRATASE; ANIMALS; CATALASE; CELL SURVIVAL; CELLS, CULTURED; CYTOCHROMES C; FIBROBLASTS; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEART VENTRICLES; HEMODYNAMICS; HOMEODOMAIN PROTEINS; HYDROGEN PEROXIDE; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; THIOREDOXINS;

ANIMALIA;

EID: 79952369026     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3163     Document Type: Article

References (49)

1. Ahsan MK, Lekli I, Ray D, Yodoi J, and Das DK. Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal 11: 2741-2758, 2009.
2. Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M, Tanovic M, Ochani K, Bacher M, Nicoletti F, Metz C, Pavlov VA, Miller EJ, and Tracey KJ. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 280: 36541-36544, 2005. (Pubitemid 41587728)
3. Baugh JA and Bucala R. Macrophage migration inhibitory factor. Crit Care Med 30: S27-S35, 2002. (Pubitemid 34131159)
4. Bendrat K, Al-Abed Y, Callaway DJ, Peng T, Calandra T, Metz CN, and Bucala R. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 36: 15356-15362, 1997. (Pubitemid 27528002)
5. Bolli R. Causative role of oxyradicals in myocardial stunning: a proven hypothesis: a brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction. Basic Res Cardiol 93: 156-162, 1998. (Pubitemid 28339970)
6. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, and David JR. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189: 341-346, 1999. (Pubitemid 29063255)
7. Bulteau AL, Lundberg KC, Ikeda-Saito M, Isaya G, and Szweda LI. Reversible redox-dependent modulation of mi-tochondrial aconitase and proteolytic activity during in vivo cardiac ischemia=reperfusion. Proc Natl Acad Sci USA 102: 5987-5991, 2005. (Pubitemid 40594242)
8. Buttke TM and Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7-10, 1994.
9. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, and Glauser MP. Protection from septic shock by neutralization of mac-rophage migration inhibitory factor. Nat Med 6: 164-170, 2000. (Pubitemid 30082360)
10. Calandra T and Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800, 2003. (Pubitemid 37328657)
11. Chagnon F, Metz CN, Bucala R, and Lesur O. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res 96: 1095-1102, 2005. (Pubitemid 40791382)
12. Dhanantwari P, Nadaraj S, Kenessey A, Chowdhury D, Al-Abed Y, Miller EJ, and Ojamaa K. Macrophage migration inhibitory factor induces cardiomyocyte apoptosis. Biochem Biophys Res Commun 371: 298-303, 2008.
13. Fingerle-Rowson G, Kaleswarapu DR, Schlander C, Kabgani N, Brocks T, Reinart N, Busch R, Schutz A, Lue H, Du X, Liu A, Xiong H, Chen Y, Nemajerova A, Hallek M, Bernhagen J, Leng L, and Bucala R. A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Mol Cell Biol 29: 1922-1932, 2009.
14. Frangogiannis NG. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem 13: 1877-1893, 2006.
15. Garner LB, Willis MS, Carlson DL, DiMaio JM, White MD, White DJ, Adams GAt, Horton JW, and Giroir BP. Macro-phage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am J Physiol Heart Circ Physiol 285: H2500-H2509, 2003. (Pubitemid 37443067)
16. Halestrap AP, Clarke SJ, and Javadov SA. Mitochondrial permeability transition pore opening during myocardial re-perfusion: a target for cardioprotection. Cardiovasc Res 61: 372-385, 2004. (Pubitemid 38210145)
17. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'Heuil D, Huang PL, and Lefer DJ. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 276: H1567-H1573, 1999. (Pubitemid 29246543)
18. Jones SP, Hoffmeyer MR, Sharp BR, Ho YS, and Lefer DJ. Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 284: H277-H282, 2003. (Pubitemid 36076295)
19. Kenessey A, Sullivan EA, and Ojamaa K. Nuclear localization of protein kinase C-alpha induces thyroid hormone receptor-alpha1 expression in the cardiomyocyte. Am J Physiol Heart Circ Physiol 290: H381-H389, 2006.
20. Kim SH, Kang KA, Zhang R, Piao MJ, Ko DO, Wang ZH, Chae SW, Kang SS, Lee KH, Kang HK, Kang HW, and Hyun JW. Protective effect of esculetin against oxidative stress-induced cell damage via scavenging reactive oxygen species. Acta Pharmacol Sin 29: 1319-1326, 2008.
21. Kleemann R, Kapurniotu A, Frank RW, Gessner A, Mischke R, Flieger O, Juttner S, Brunner H, and Bernhagen J. Dis-ulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol 280: 85-102, 1998. (Pubitemid 28312808)
22. Kleemann R, Mischke R, Kapurniotu A, Brunner H, and Bernhagen J. Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with gluta-thione and dihydrolipoamide: potential role in cellular redox processes. FEBS Lett 430: 191-196, 1998. (Pubitemid 28337910)
23. Kleemann R, Rorsman H, Rosengren E, Mischke R, Mai NT, and Bernhagen J. Dissection of the enzymatic and immu-nologic functions of macrophage migration inhibitory factor: full immunologic activity of N-terminally truncated mutants. Eur J Biochem 267: 7183-7193, 2000.
24. Kondo N, Ishii Y, Son A, Sakakura-Nishiyama J, Kwon YW, Tanito M, Nishinaka Y, Matsuo Y, Nakayama T, Taniguchi M, and Yodoi J. Cysteine-dependent immune regulation by TRX and MIF=GIF family proteins. Immunol Lett 92: 143-147, 2004. (Pubitemid 38470061)
25. Krause G, Lundstrom J, Barea JL, Pueyo de la Cuesta C, and Holmgren A. Mimicking the active site of protein disulfide-isomerase by substitution of proline 34 in Escherichia coli thioredoxin. J Biol Chem 266: 9494-9500, 1991. (Pubitemid 21906684)
26. Kumar D and Jugdutt BI. Apoptosis and oxidants in the heart. J Lab Clin Med 142: 288-297, 2003. (Pubitemid 37487398)
27. Lillig CH and Holmgren A. Thioredoxin and related molecules: from biology to health and disease. Antioxid Redox Signal 9: 25-47, 2007. (Pubitemid 44901873)
28. Lin X, Sakuragi T, Metz CN, Ojamaa K, Skopicki HA, Wang P, Al-Abed Y, and Miller EJ. Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis. Shock 24: 556-563, 2005.
29. Miller EJ, Li J, Leng L, McDonald C, Atsumi T, Bucala R, and Young LH. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451: 578-582, 2008. (Pubitemid 351186266)
30. Murphy E and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88: 581-609, 2008. (Pubitemid 351520088)
31. Nagy N, Malik G, Tosaki A, Ho YS, Maulik N, and Das DK. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J Mol Cell Cardiol 44: 252-260, 2008.
32. Nguyen MT, Beck J, Lue H, Funfzig H, Kleemann R, Kool-wijk P, Kapurniotu A, and Bernhagen J. A 16-residue pep-tide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions. J Biol Chem 278: 33654-33671, 2003. (Pubitemid 37553198)
33. Nguyen MT, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D, Wagner E, Braun A, and Bernhagen J. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol 170: 3337-3347, 2003. (Pubitemid 36302213)
34. Noels H, Bernhagen J, and Weber C. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis. Trends Cardiovasc Med 19: 76-86, 2009.
35. Qi D, Hu X, Wu X, Merk M, Leng L, Bucala R, and Young LH. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia= reperfusion. J Clin Invest 119: 3807-3816, 2009.
36. Robin E, Guzy RD, Loor G, Iwase H, Waypa GB, Marks JD, Hoek TL, and Schumacker PT. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem 282: 19133-19143, 2007. (Pubitemid 47100157)
37. 0-dichloro-fluorescein-diacetate. J Immunol Methods 156: 39-45, 1992.
38. Sakuragi T, Lin X, Metz CN, Ojamaa K, Kohn N, Al-Abed Y, and Miller EJ. Lung-derived macrophage migration inhibitory factor in sepsis induces cardio-circulatory depression. Surg Infect (Larchmt) 8: 29-40, 2007. (Pubitemid 46598293)
39. Schwalb H, Olivson A, Li J, Houminer E, Wahezi SE, Opie LH, Maulik D, Borman JB, and Powell SR. Nicorandil decreases postischemic actin oxidation. Free Radic Biol Med 31: 607-614, 2001. (Pubitemid 32777861)
40. Sherry B, Yarlett N, Strupp A, and Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc Natl Acad Sci USA 89: 3511-3515, 1992.
41. Son A, Kato N, Horibe T, Matsuo Y, Mochizuki M, Mitsui A, Kawakami K, Nakamura H, and Yodoi J. Direct association of thioredoxin-1 (TRX) with macrophage migration inhibitory factor (MIF): regulatory role of TRX on MIF internali-zation and signaling. Antioxid Redox Signal 11: 2595-2605, 2009.
42. Sun C, Li H, Leng L, Raizada MK, Bucala R, and Sumners C. Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity. J Neurosci 24: 9944-9952, 2004. (Pubitemid 39463575)
43. Swope MD, Sun HW, Klockow B, Blake P, and Lolis E. Macrophage migration inhibitory factor interactions with glutathione and S-hexylglutathione. J Biol Chem 273: 14877-14884, 1998. (Pubitemid 28272776)
44. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, et al. ATL-derived factor (ADF), an IL-2 receptor=Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8: 757-764, 1989. (Pubitemid 19273247)
45. Takahashi M, Nishihira J, Shimpo M, Mizue Y, Ueno S, Mano H, Kobayashi E, Ikeda U, and Shimada K. Macro-phage migration inhibitory factor as a redox-sensitive cyto-kine in cardiac myocytes. Cardiovasc Res 52: 438-445, 2001. (Pubitemid 33153106)
46. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, and Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP ki-nase signalling in fibroblasts. Nature 456: 980-984, 2008.
47. Von Harsdorf R, Li PF, and Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99: 2934-2941, 1999. (Pubitemid 29258983)
48. Zernecke A, Bernhagen J, and Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117: 1594-1602, 2008. (Pubitemid 351440647)
49. Zhu X, Zuo L, Cardounel AJ, Zweier JL, and He G. Characterization of in vivo tissue redox status, oxygenation, and formation of reactive oxygen species in postischemic myocardium. Antioxid Redox Signal 9: 447-455, 2007. (Pubitemid 46331759)